{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T18:17:03Z","timestamp":1790446623081,"version":"4.1.0"},"reference-count":32,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"PRIDST 2021-2027","award":["BG16RFPR002-1.014-0002-C001"],"award-info":[{"award-number":["BG16RFPR002-1.014-0002-C001"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Lung adenocarcinoma exhibits a heterogeneous molecular landscape shaped by key oncogenic drivers and tumor suppressor gene alterations. Mutation frequencies vary geographically, influenced by genetic ancestry and environmental factors. However, the molecular profile of lung adenocarcinoma in Bulgarian patients remains largely uncharacterized. We conducted a prospective study of 147 Bulgarian patients with metastatic lung adenocarcinoma, analyzing clinicopathologic features and somatic mutation frequencies using next-generation sequencing. Key mutations and their prevalence were assessed and compared with published data from other populations. The cohort included predominantly male patients (68.0%) with a median age of 67 years. TP53 mutations were most frequent (41.5%), followed by EGFR alterations (19.0%) and KRAS c.34G&gt;T (p.Gly12Cys) (17.0%). Over half of the patients (51.0%) harbored two or more gene mutations. Mutation frequencies aligned closely with European cohorts, exhibiting a lower prevalence of EGFR mutations compared to East Asian populations. This study characterizes the molecular landscape of lung adenocarcinoma in Bulgaria, highlighting the predominance of TP53 and KRAS mutations. The findings emphasize the need for comprehensive molecular profiling to inform targeted therapies and support precision oncology approaches tailored to the Bulgarian population. Further research is needed to validate these results and improve clinical outcomes.<\/jats:p>","DOI":"10.3390\/ijms26147017","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T13:59:11Z","timestamp":1753106351000},"page":"7017","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Molecular Landscape of Metastatic Lung Adenocarcinoma in Bulgarian Patients\u2014A Prospective Study"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9925-9025","authenticated-orcid":false,"given":"George","family":"Dimitrov","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Medical University of Sofia, University Hospital \u201cTsaritsa Yoanna\u201d, 1527 Sofia, Bulgaria"},{"name":"Centre of Competence in Personalized Medicine, 3D and Telemedicine, Robotic Assisted and Minimally Invasive Surgery\u2014Leonardo da Vinci, 5800 Pleven, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladislav","family":"Nankov","sequence":"additional","affiliation":[{"name":"Centre of Competence in Personalized Medicine, 3D and Telemedicine, Robotic Assisted and Minimally Invasive Surgery\u2014Leonardo da Vinci, 5800 Pleven, Bulgaria"},{"name":"Department of Anatomy, Histology, Cytology and Biology, Medical University of Pleven, 5800 Pleven, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Chilingirova","sequence":"additional","affiliation":[{"name":"Medical Oncology Clinic, Heart and Brain Hospital, 5804 Pleven, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zornitsa","family":"Kamburova","sequence":"additional","affiliation":[{"name":"Centre of Competence in Personalized Medicine, 3D and Telemedicine, Robotic Assisted and Minimally Invasive Surgery\u2014Leonardo da Vinci, 5800 Pleven, Bulgaria"},{"name":"Department of Medical Genetics, Medical University of Pleven, 5800 Pleven, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savelina","family":"Popovska","sequence":"additional","affiliation":[{"name":"Centre of Competence in Personalized Medicine, 3D and Telemedicine, Robotic Assisted and Minimally Invasive Surgery\u2014Leonardo da Vinci, 5800 Pleven, Bulgaria"},{"name":"Department of Clinical Pathology, Medical University of Pleven, 5800 Pleven, Bulgaria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1016\/S1470-2045(15)00077-7","article-title":"Genomic alterations in lung adenocarcinoma","volume":"16","author":"Devarakonda","year":"2015","journal-title":"Lancet Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.cell.2012.08.029","article-title":"Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing","volume":"150","author":"Imielinski","year":"2012","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"8375","DOI":"10.1038\/s41467-023-43732-y","article-title":"Whole-genome sequencing reveals the molecular implications of the stepwise progression of lung adenocarcinoma","volume":"14","author":"Haga","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5472","DOI":"10.1038\/s41467-019-13460-3","article-title":"Genomic and immune profiling of pre-invasive lung adenocarcinoma","volume":"10","author":"Chen","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.jtho.2019.07.031","article-title":"Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma","volume":"14","author":"Zhang","year":"2019","journal-title":"J. Thorac. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/1878-0261.13550","article-title":"Transcriptional analysis of landmark molecular pathways in lung adenocarcinoma results in a clinically relevant classification with potential therapeutic implications","volume":"18","author":"Alay","year":"2024","journal-title":"Mol. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1038\/s41388-021-01909-z","article-title":"Aggressive early-stage lung adenocarcinoma is characterized by epithelial cell plasticity with acquirement of stem-like traits and immune evasion phenotype","volume":"40","author":"Melocchi","year":"2021","journal-title":"Oncogene"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41588-019-0569-6","article-title":"Genomic landscape of lung adenocarcinoma in East Asians","volume":"52","author":"Chen","year":"2020","journal-title":"Nat. Genet."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e20171","DOI":"10.1016\/j.heliyon.2023.e20171","article-title":"Different gene alterations in patients with non-small-cell lung cancer between the eastern and southern China","volume":"9","author":"Liu","year":"2023","journal-title":"Heliyon"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Shi, H., Seegobin, K., Heng, F., Zhou, K., Chen, R., Qin, H., Manochakian, R., Zhao, Y., and Lou, Y. (2022). Genomic landscape of lung adenocarcinomas in different races. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.946625"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1038\/s41467-023-38196-z","article-title":"Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population","volume":"14","author":"Shi","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Rueda-Zarazua, B., Guti\u00e9rrez, H., Garc\u00eda-Ortiz, H., Orozco, L., Ram\u00edrez-Mart\u00ednez, G., Jim\u00e9nez-Alvarez, L., Bola\u00f1os-Morales, F.V., Zu\u00f1iga, J., \u00c1vila-Moreno, F., and Melendez-Zajgla, J. (2025). A Pilot Study: Contrasting Genomic Profiles of Lung Adenocarcinoma Between Patients of European and Latin American Ancestry. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26104865"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1158\/1078-0432.CCR-10-2185","article-title":"Genomic profiles specific to patient ethnicity in lung adenocarcinoma","volume":"17","author":"Dalmasso","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Forsythe, M.L., Alwithenani, A., Bethune, D., Castonguay, M., Drucker, A., Flowerdew, G., French, D., Fris, J., Greer, W., and Henteleff, H. (2020). Molecular profiling of non-small cell lung cancer. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0236580"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e21013","DOI":"10.1200\/JCO.2023.41.16_suppl.e21013","article-title":"Frequency and patterns of TP53 mutations in lung cancer","volume":"41","author":"Yang","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"107293","DOI":"10.1016\/j.lungcan.2023.107293","article-title":"KRAS G12C in advanced NSCLC: Prevalence, co-mutations, and testing","volume":"184","author":"Lim","year":"2023","journal-title":"Lung Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.lungcan.2017.08.021","article-title":"EGFR mutation prevalence in Asia-Pacific and Russian patients with advanced NSCLC of adenocarcinoma and non-adenocarcinoma histology: The IGNITE study","volume":"113","author":"Han","year":"2017","journal-title":"Lung Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/S1470-2045(23)00444-8","article-title":"Global variations in lung cancer incidence by histological subtype in 2020: A population-based study","volume":"24","author":"Zhang","year":"2023","journal-title":"Lancet Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13000-019-0789-1","article-title":"Analysis of the frequency of oncogenic driver mutations and correlation with clinicopathological characteristics in patients with lung adenocarcinoma from Northeastern Switzerland","volume":"14","author":"Grosse","year":"2019","journal-title":"Diagn. Pathol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature13385","article-title":"Comprehensive molecular profiling of lung adenocarcinoma","volume":"511","author":"Collisson","year":"2014","journal-title":"Nature"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Ferrara, M.G., Di Noia, V., D\u2019Argento, E., Vita, E., Damiano, P., Cannella, A., Ribelli, M., Pilotto, S., Milella, M., and Tortora, G. (2020). Oncogene-Addicted Non-Small-Cell Lung Cancer: Treatment Opportunities and Future Perspectives. Cancers, 12.","DOI":"10.3390\/cancers12051196"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/s41568-019-0179-8","article-title":"Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy","volume":"19","author":"Skoulidis","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Frille, A., Boeschen, M., Wirtz, H., Stiller, M., Bl\u00e4ker, H., and von Laffert, M. (2024). TP53 co-mutations in advanced lung adenocarcinoma: Comparative bioinformatic analyses suggest ambivalent character on overall survival alongside KRAS, STK11 and KEAP1 mutations. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1357583"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Kobayashi, N., Miura, K., Kaneko, A., Matsumoto, H., Somekawa, K., Hirose, T., Kajita, Y., Tanaka, A., Teranishi, S., and Sairenji, Y. (2023). Tailoring Therapeutic Strategies in Non-Small-Cell Lung Cancer: The Role of Genetic Mutations and Programmed Death Ligand-1 Expression in Survival Outcomes. Cancers, 15.","DOI":"10.3390\/cancers15215248"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1056\/NEJMoa2103695","article-title":"Sotorasib for Lung Cancers with KRAS p.G12C Mutation","volume":"384","author":"Skoulidis","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1038\/s41467-024-47080-3","article-title":"Nanoparticles targeting mutant p53 overcome chemoresistance and tumor recurrence in non-small cell lung cancer","volume":"15","author":"Bi","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Spagnolo, C.C., Ciappina, G., Giovannetti, E., Squeri, A., Granata, B., Lazzari, C., Pretelli, G., Pasello, G., and Santarpia, M. (2023). Targeting MET in Non-Small Cell Lung Cancer (NSCLC): A New Old Story?. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241210119"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1097\/CM9.0000000000002195","article-title":"Treating non-small cell lung cancer by targeting the PI3K signaling pathway","volume":"135","author":"Jiang","year":"2022","journal-title":"Chin. Med. J."},{"key":"ref_29","first-page":"271","article-title":"Mitigating the Morbidity of Financial Toxicity in Cancer Care","volume":"12","author":"Shankaran","year":"2021","journal-title":"J. Adv. Pract. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/nm.3729","article-title":"Anchored multiplex PCR for targeted next-generation sequencing","volume":"20","author":"Zheng","year":"2014","journal-title":"Nat. Med."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Pei, X.M., Yeung, M.H.Y., Wong, A.N.N., Tsang, H.F., Yu, A.C.S., Yim, A.K.Y., and Wong, S.C.C. (2023). Targeted Sequencing Approach and Its Clinical Applications for the Molecular Diagnosis of Human Diseases. Cells, 12.","DOI":"10.3390\/cells12030493"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jmoldx.2017.01.011","article-title":"Guidelines for Validation of Next-Generation Sequencing-Based Oncology Panels: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists","volume":"19","author":"Jennings","year":"2017","journal-title":"J. Mol. Diagn."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/14\/7017\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:13:28Z","timestamp":1760033608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/14\/7017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":32,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["ijms26147017"],"URL":"https:\/\/doi.org\/10.3390\/ijms26147017","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]}}}